BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), eine Tochtergesellschaft der Nordic Group B.V. (Nordic Pharma), gab heute bekannt, dass der herausragende Augenarzt Eric D. Donnenfeld, MD, den Chair des U.S. Medical Advisory Board (M…
Author: Business Wire
Riassunto: Nordic Group B.V. attraverso la sua controllata Amring Pharmaceuticals Inc., nomina Presidente del Medical Advisory Board il Dott. Eric D. Donnenfeld, innovatore in oftalmologia
BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), una controllata di Nordic Group B.V. (Nordic Pharma), ha annunciato oggi che l’eminente oftalmologo Eric D. Donnenfeld, MD presiederà il suo Medical Advisory Board (MAB), il Comitato m…
Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair
BERWYN, Pa.–(BUSINESS WIRE)–Amring, a subsidiary of Nordic Pharma, will have preeminent ophthalmologist Eric D. Donnenfeld, MD Chair its U.S. Medical Advisory Board.
LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the Company’s fourth quart…
白内障手術用レンズの選択に、スイス製の新機能
スイス・ニューシャテル–(BUSINESS WIRE)–（ビジネスワイヤ） — スイス・アドバンスト・ビジョン（SAV-IOL SA）は、当社のトーリックカリキュレーターに新機能を導入し、計算エクスペリエンス全体を改良したことを発表します。この世界初の機能により、眼科医はウェブベースのコンフィギュレーターを使用して患者の光学パラメータに基づいて最良の切開位置を定義し、術後に残る乱視を最低限に抑えることができます。この機能はすべてのレンズに導入されます。 SAV-IOL Toric Calcul…
Novos recursos fabricados na Suíça para a seleção de lentes para cirurgia de catarata
NEUCHATEL, Suíça–(BUSINESS WIRE)–A empresa Swiss Advanced Vision (SAV-IOL SA) anunciou o lançamento de novos recursos para a sua calculadora tórica, que aprimora a experiência geral de cálculo. Pela primeira vez, os oftalmologistas serão capazes de u…
白内障手术镜片选择的新瑞士制造特性
瑞士, 纳沙泰尔–(BUSINESS WIRE)–(美国商业资讯)– Swiss Advanced Vision （SAV-IOL SA）宣布推出其扭曲计算器的新功能，以改善整体计算体验。眼科医生首次能够利用基于患者光学参数的网络配置器来帮助确定最佳的切口位置，以最小化手术后残留的散光。而且，适用于所有类型的镜片。 SAV-IOL扭曲计算器有助于选择扭曲人工晶体，帮助矫正散光，这是一种普遍的眼睛状况，会导致视力模糊、不适和潜在的头痛。 除了独特的切口位置优化工具能指示残余散光何时在切口角度下达…
白內障手術鏡片選擇的瑞士製造新特性
瑞士, 紐夏泰爾–(BUSINESS WIRE)–(美國商業資訊)– Swiss Advanced Vision（SAV-IOL SA）宣布推出其Toric計算器的新功能，以提升整體計算體驗。這是眼科醫生首次能夠使用網絡配置器，根據患者的光學參數幫助確定最佳的切口位置，以最大限度地減少手術後的殘餘散光。而且，適用於所有類型的鏡片。 SAV-IOL Toric Calculator能夠協助選擇扭曲人工晶體，以糾正散光，這是一種普遍的眼睛問題，會導致視力模糊、不適和潛在的頭痛。 除了獨特的切口位置…
Nuevas funciones Swiss Made para la selección de lentes para la cirugía de cataratas
NEUCHATEL, Suiza–(BUSINESS WIRE)–La empresa Swiss Advanced Vision (SAV-IOL SA) anunció el lanzamiento de nuevas funciones para su Calculadora de Tóricos que mejoran la experiencia general de cálculo. Por primera vez, los oftalmólogos podrán utilizar …
Samenvatting: In Zwitserland krijgt de selectie van lenzen nieuwe functies voor staaroperaties
NEUCHATEL, Zwitserland–(BUSINESS WIRE)–Het bedrijf Swiss Advanced Vision (SAV-IOL SA) heeft aangekondigd dat het nieuwe functies voor zijn Toric Calculator heeft ontwikkeld om de algehele berekeningservaring te verbeteren. Voor het eerst kunnen oogar…
Neue in der Schweiz entwickelte Funktionen zur Auswahl der Linsen für die Kataraktchirurgie
NEUCHATEL, Schweiz–(BUSINESS WIRE)–Das Unternehmen Swiss Advanced Vision (SAV-IOL SA) hat die Einführung neuer Funktionen für seinen Toric Calculator bekannt gegeben, durch die die Benutzerfreundlichkeit bei der Berechnung insgesamt verbessert wurde….
Riassunto: Nuove funzionalità 'Swiss Made' per la selezione delle lenti nella chirurgia della cataratta
NEUCHÂTEL, Svizzera–(BUSINESS WIRE)–L’azienda Swiss Advanced Vision (SAV-IOL SA) ha annunciato il lancio di nuove funzionalità del suo Calcolatore torico che migliorano l’esperienza globale di calcolo: per la prima volta in assoluto gli oftalmologi h…
New Swiss Made Features for Cataract Surgery Lens Selection
NEUCHATEL, Switzerland–(BUSINESS WIRE)– #astigmatism–Innovative Swiss-made calculator to help define the best incision location on top of enhancing cataract surgery lens selection
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
jCyte, Inc. Announces Positive Pre-Phase 3 FDA Type B Meeting and Outlines Plans to Start Pivotal Trial of jCell® for Retinitis Pigmentosa in the Second Half of 2024
NEWPORT BEACH, Calif.–(BUSINESS WIRE)– #RP–jCyte, Inc., a pioneering biotechnology company dedicated to preserving and restoring vision in patients with retinitis pigmentosa (RP) and other degenerative retinal disorders, is pleased to announce the s…
Aptar Digital Health Announces Acquisition of Healint to Reinforce Digital Health Portfolio and Drive Future Growth
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar Digital Health Announces Acquisition of Healint to Reinforce Digital Health Portfolio and Drive Future Growth
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its fourth-quarter and full-year 2023 financial results. “Revenue …
OcuSciences Welcomes Michael Patane, PhD, to its Board of Directors
ANN ARBOR, Mich.–(BUSINESS WIRE)–OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced the addition of Michael Patane, PhD, to its Board of Directors. Dr. Pata…
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that it wil…
Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announce…